Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,925.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,331
  • Market Cap: £152.83m
  • Beta: 0.01

Bioventix appoints Bruce Hiscox as chief financial officer

By Iain Gilbert

Date: Wednesday 01 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.

The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.

As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,925.00p
Change Today 25.00p
% Change 0.86 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 1,331
Shares Issued 5.22m
Market Cap £152.83m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.43% below the market average25.43% below the market average25.43% below the market average25.43% below the market average25.43% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
58.39% below the market average58.39% below the market average58.39% below the market average58.39% below the market average58.39% below the market average
17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average
Income
38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average38.08% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
14.51% below the market average14.51% below the market average14.51% below the market average14.51% below the market average14.51% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 30-May-2025

Time Volume / Share Price
16:03 15 @ 2,950.00p
15:40 67 @ 2,932.00p
15:18 170 @ 2,909.50p
14:24 600 @ 2,900.00p
14:17 50 @ 2,932.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page